NEW YORK (GenomeWeb News) – Agilent Technologies has appointed Sam Mohan to be Southeast Asia regional manager for its Life Sciences Group. Mohan will be responsible for building and implementing the firm's SE Asian product strategies, as well as its lifecycle management, partner integration, global branding, and communications. Mohan formerly was sales director of Cell Biosciences and he was a manager at Amersham Biosciences and Bio-Rad Laboratories in the life sciences and clinical diagnostics division.
T2 Biosystems has formed its clinical advisory board. The new CAB includes Peter Pappas, a principal investigator at the University of Alabama Birmingham; Jeff Groeger, chief of urgent care at Memorial Sloan Kettering hospital; Eric Rosenberg, co-director of the microbiology lab at Massachusetts General Hospital; and Lou Rice, chair of the Department of Medicine at Brown University.
Jeffrey Trent, research director of the Translational Genomics Research Institute and the Van Andel Research Institute, has been appointed to be foreign trade counselor of Luxembourg in the US. In the position, Trent will work with the Luxembourg Trade and Investment Offices in San Francisco and New York.
Fluidigm Director Raymond Whitaker will not stand for his position on the company's board of directors at the firm's next annual stockholder meeting. The company's board also has approved an increase in base salary for President and CEO Gajus Worthington from $319,000 to $350,000.
RainDance Technologies has tapped Andy Watson to serve as its VP and chief marketing officer. In the role, he will lead marketing and strategy efforts for the company's targeted sequencing business and for the launch of its digital PCR and single cell analysis products. Watson formerly was VP of SOLiD Sequencing product management at Life Technologies, and he led Applied Biosystems' capillary electrophoresis sequencing business. Watson also was a founder of Quantum Dot Corporation, and he led development of technologies and software for large-scale DNA analysis at Sequana Therapeutics.
Shareholders of Thermo Fisher Scientific have re-elected several members of the board of directors to serve until the 2014 annual meeting. The re-elected directors include Thomas Lynch, William Parrett, Michael Porter, and Scott Sperling.
Shareholders of Luminex this week re-elected three members of the firm's board of directors to serve for an additional three years. The three directors are Fred Goad, Jay Johnston, and Jim Kever.
Arrayed imaging company Adarza has added Heiner Dreismann and James Senall to its board of directors. Dreismann formerly was CEO of Roche Molecular Systems among other positions at Roche, and Senall formerly was managing director of business development at the Greater Rochester Enterprise.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.